NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired NantHealth, Inc. (NASDAQ: NH) securities between June 1, 2016 and March 6, 2017 (the “Class Period”). Investors have until May 8, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
On March 6, 2017, the STAT news organization published an article alleging NantHealth’s CEO’s donation to the University of Utah required the university to spend $10 million on work performed by NantHealth, an arrangement which enabled NantHealth to inflate by more than 50 percent the number of test orders it reported to investors in 2016. Additionally, the article quoted two tax experts stating that the deal appeared to violate federal tax rules governing charitable donations.
Following this news, NantHealth shares declined $1.67 per share, or over 23.2%, on March 6, 2017 to close at $5.50 on March 6, 2017.
If you purchased or otherwise acquired NantHealth securities during the Class Period and suffered a loss or continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa A. Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the NantHealth lawsuit, please go to www.bespc.com/nanthealth. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.